BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Nintedanib (Vargatef) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Nintedanib (Vargatef)\, from ClinicalTria
 ls.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07485920-11044@assetmemo.bio
DTSTAMP:20261121T005706Z
DTSTART;VALUE=DATE:20281210
DTEND;VALUE=DATE:20281211
SUMMARY:Nintedanib (Vargatef): Phase 4 readout est. (NCT07485920)
DESCRIPTION:Nintedanib (Vargatef)\, phase 4.\nStudy: A Prospective\, Multic
 enter Exploratory Clinical Study on Consolidation Therapy With Tislelizuma
 b Combined With Nintedanib for Limited-stage Small Cell Lung Cancer\nEstim
 ated primary completion: 10 December 2028. This is a ClinicalTrials.gov es
 timate\, not a confirmed readout date\, and it can move.\nDrug page: https
 ://assetmemo.bio/drug/nintedanib-vargatef#upcoming-events\nRegistry record
 : https://clinicaltrials.gov/study/NCT07485920
URL:https://assetmemo.bio/drug/nintedanib-vargatef#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
